Drugs · acquisition-cost intelligence
Evesse
hydrocortisone butyrate· ingredient hydrocortisoneCorticosteroids· HYDROCORTISONE BUTYRATE 1 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.69995
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 4 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other hydrocortisone products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Absolut Skin Corticosoothe Anti-Itch | $0.06272 | −$0.63720 |
| Hydrocortisone | $0.07424 | −$0.62570 |
| anti itch | $0.07838 | −$0.62160 |
| ANTI-ITCH FEMININE CARE | $0.08285 | −$0.61710 |
| Hydrocortisone | $0.10310 | −$0.59680 |
| Hydrocortisone Rectal Suspension (Retention) | $0.16179 | −$0.53820 |
| CORTEF | $0.19405 | −$0.50590 |
| hydrocortisone | $0.22379 | −$0.47620 |
Medicare Part D coverage · CY2026
On 20 plan formularies · typical tier 2
Prior auth 0% · Step therapy 0% · Quantity limit 40% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.